Methods In this ongoing non-inferiority design RCT, patients with dysplastic BE or residual
BE after endoscopic resection (ER) of a visible lesion were included and randomly assigned …

OBJECTIVE: Radiofrequency ablation (RFA)±endoscopic resection (ER) is the preferred
treatment for early neoplasia in Barrett's oesophagus (BE). We aimed to report short-term …

Background and aims Endoscopic mucosal resection (EMR) and radiofrequency ablation
(RFA) for Barrett's esophagus (BE)-related high-grade dysplasia (HGD) and early …

Barrett's esophagus (BE) is the precursor for esophageal adenocarcinoma (EAC). The risk of
progression from nondysplastic BE (NDBE) to EAC is 30-fold to 125-fold greater than in the …

Background and Aims Barrett's esophagus with low-grade dysplasia (BE-LGD) carries a risk
of progression to Barrett's esophagus with high-grade dysplasia (BE-HGD) and esophageal …

Esophageal adenocarcinoma continues to be a vexing problem for the Western world,
where its incidence has increased at an alarming rate and is projected to continue to …

Barrett's esophagus is a condition in which the normal squamous lining of the esophagus
has been replaced by columnar epithelium containing intestinal metaplasia induced by …

In the past 2 decades, endoscopic therapy has been proven to be an effective, safe, and
minimally invasive alternative to surgery for Barrett's esophagus (BE) with early neoplasia …

Radiofrequency ablation of Barrett's esophagus with low-grade dysplasia is recommended
in recent American College of Gastroenterology guidelines, with endoscopic surveillance …

See “Recurrence of esophageal intestinal metaplasia after endoscopic mucosal resection
and radiofrequency ablation of Barrett's esophagus: results from a US multicenter …